Please login to Zacks.com or register to post a comment.
| No Recent Quote currently available |
|
My Portfolio Tracker One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts. Set yours up today. |
Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.
Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.
Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.
My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.
| Company Name | Symbol | %Change |
|---|---|---|
| SCIENTIFIC L | SCIL | 8.00% |
| NATUS MEDICA | BABY | 6.11% |
| SUMMER INFAN | SUMR | 6.02% |
| RADIANT LOGI | RLGT | 5.32% |
| NEW ORIENTAL | EDU | 4.51% |
Please login to Zacks.com or register to post a comment.
Resources
Client Support
Zacks Research is Reported On:
Zacks Investment Research
is an A+ Rated BBB
Accredited Business.
Copyright 2013 Zacks Investment Research
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.
Visit performance for information about the performance numbers displayed above.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This page is temporarily not available. Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext. 9339.
Guess?, Inc. ( GES - Analyst Report ) is slated to release its third quarter fiscal 2013 results after the market closes on November 28, 2012. The Zacks Consensus Estimate for the third quarter is pegged at 44 cents (year-over-year decline of 38.0%) on revenues of $621 million (year-over-year decline of 3.4%). Both earnings and revenue estimates are within management’s guidance range. The guidance includes earnings in the range of 42 cents to 46 cents and revenue in the range of $620 million to $630 million.
Second Quarter Recap
Guess? Inc’s second quarter fiscal 2013 adjusted earnings of 49 cents missed the Zacks Consensus Estimate of 50 cents per share and declined 41.7% from the year-ago earnings of 84 cents. Earnings declined due to a decrease in revenues.
Revenues in the quarter dropped 6.2% to $635.4 million from $677.2 million in the prior-year quarter due to lower traffic in North American stores. Revenue increased 0.4% on a currency neutral basis.
Operating margin shrank 770 basis points year over year to 9.0%, reflecting higher investment in advertising & marketing along with higher occupancy & selling costs in Europe.
Agreement of Estimate Revisions
Over the past 30 days, only 1 out of the 12 analysts covering the stock revised its earnings estimate for the third quarter of fiscal 2013 in the downward direction. None of the analysts revised their estimates in the positive direction.
Likewise for fiscal 2013, only 1 out of the 12 analysts changed its estimates in the negative direction over the past 30 days. None of the analysts have revised it in the opposite direction.
The downward revision in estimates can be attributed to the existing economic pressure, particularly in Europe along with foreign currency headwinds, which have been hurting margins consistently.
Magnitude of Estimate Revisions
The Zacks Consensus Estimate for the third quarter has remained static over the past 30 days at 44 cents. For fiscal year 2013, the Zacks Consensus Estimate declined from $2.18 per share to $2.17 per share over the past 30 days.
Surprise History
Guess? has missed earnings estimates in two of the last four quarters. It has met the earnings estimate in one quarter while surpassing estimates in one of the last four quarters. The earnings surprise ranges from a negative 2.74% to a positive 15.38%, with the average earnings surprise is 3.55%.
Our Recommendation
Currently, we have a Neutral recommendation on the stock. Guess? holds a Zacks #5 Rank (short-term ‘Strong Sell’ rating) in sharp contrast to its peer, Gap, Inc. ( GPS - Analyst Report ) , which holds a Zacks #1 Rank (short-term ‘Strong Buy’ rating).
Read the full Analyst Report on GPS
Read the full Analyst Report on GES